122 related articles for article (PubMed ID: 28498473)
1. Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti-apoptotic proteins.
Račkauskas R; Zhou D; Ūselis S; Strupas K; Herr I; Schemmer P
Oncol Rep; 2017 Jun; 37(6):3660-3666. PubMed ID: 28498473
[TBL] [Abstract][Full Text] [Related]
2. Sulforaphane-cisplatin combination inhibits the stemness and metastatic potential of TNBCs via down regulation of sirtuins-mediated EMT signaling axis.
Sinha S; Sharma S; Sharma A; Vora J; Shrivastava N
Phytomedicine; 2021 Apr; 84():153492. PubMed ID: 33640782
[TBL] [Abstract][Full Text] [Related]
3. Epigallocatechin gallate and sulforaphane combination treatment induce apoptosis in paclitaxel-resistant ovarian cancer cells through hTERT and Bcl-2 down-regulation.
Chen H; Landen CN; Li Y; Alvarez RD; Tollefsbol TO
Exp Cell Res; 2013 Mar; 319(5):697-706. PubMed ID: 23333498
[TBL] [Abstract][Full Text] [Related]
4. Optimizing combination therapy in prostate cancer: mechanistic insights into the synergistic effects of Paclitaxel and Sulforaphane-induced apoptosis.
Habib TN; Altonsy MO; Ghanem SA; Salama MS; Hosny MA
BMC Mol Cell Biol; 2024 Mar; 25(1):5. PubMed ID: 38438917
[TBL] [Abstract][Full Text] [Related]
5. Sulforaphane induces p53‑deficient SW480 cell apoptosis via the ROS‑MAPK signaling pathway.
Lan H; Yuan H; Lin C
Mol Med Rep; 2017 Nov; 16(5):7796-7804. PubMed ID: 28944886
[TBL] [Abstract][Full Text] [Related]
6. Sulforaphane inhibits growth of human breast cancer cells and augments the therapeutic index of the chemotherapeutic drug, gemcitabine.
Hussain A; Mohsin J; Prabhu SA; Begum S; Nusri Qel-A; Harish G; Javed E; Khan MA; Sharma C
Asian Pac J Cancer Prev; 2013; 14(10):5855-60. PubMed ID: 24289589
[TBL] [Abstract][Full Text] [Related]
7. Bcl-2 degradation is an additional pro-apoptotic effect of polo-like kinase inhibition in cholangiocarcinoma cells.
Sydor S; Jafoui S; Wingerter L; Swoboda S; Mertens JC; Gerken G; Canbay A; Paul A; Fingas CD
World J Gastroenterol; 2017 Jun; 23(22):4007-4015. PubMed ID: 28652654
[TBL] [Abstract][Full Text] [Related]
8. Sulforaphane Potentiates Gemcitabine-Mediated Anti-Cancer Effects against Intrahepatic Cholangiocarcinoma by Inhibiting HDAC Activity.
Tomooka F; Kaji K; Nishimura N; Kubo T; Iwai S; Shibamoto A; Suzuki J; Kitagawa K; Namisaki T; Akahane T; Mitoro A; Yoshiji H
Cells; 2023 Feb; 12(5):. PubMed ID: 36899823
[TBL] [Abstract][Full Text] [Related]
9. Sulforaphane metabolites reduce resistance to paclitaxel via microtubule disruption.
Wang Y; Zhou Y; Zheng Z; Li J; Yan Y; Wu W
Cell Death Dis; 2018 Nov; 9(11):1134. PubMed ID: 30429459
[TBL] [Abstract][Full Text] [Related]
10. Sulforaphane inhibits cancer stem-like cell properties and cisplatin resistance through miR-214-mediated downregulation of c-MYC in non-small cell lung cancer.
Li QQ; Xie YK; Wu Y; Li LL; Liu Y; Miao XB; Liu QZ; Yao KT; Xiao GH
Oncotarget; 2017 Feb; 8(7):12067-12080. PubMed ID: 28076844
[TBL] [Abstract][Full Text] [Related]
11. Sulforaphane induces apoptosis in rhabdomyosarcoma and restores TRAIL-sensitivity in the aggressive alveolar subtype leading to tumor elimination in mice.
Bergantin E; Quarta C; Nanni C; Fanti S; Pession A; Cantelli-Forti G; Tonelli R; Hrelia P
Cancer Biol Ther; 2014 Sep; 15(9):1219-25. PubMed ID: 24971463
[TBL] [Abstract][Full Text] [Related]
12. Sulforaphane enhances the cisplatin sensitivity through regulating DNA repair and accumulation of intracellular cisplatin in ovarian cancer cells.
Gong TT; Liu XD; Zhan ZP; Wu QJ
Exp Cell Res; 2020 Aug; 393(2):112061. PubMed ID: 32437713
[TBL] [Abstract][Full Text] [Related]
13. Synergistic anticancer effects of cisplatin and histone deacetylase inhibitors (SAHA and TSA) on cholangiocarcinoma cell lines.
Asgar MA; Senawong G; Sripa B; Senawong T
Int J Oncol; 2016 Jan; 48(1):409-20. PubMed ID: 26575528
[TBL] [Abstract][Full Text] [Related]
14. ABT737 enhances cholangiocarcinoma sensitivity to cisplatin through regulation of mitochondrial dynamics.
Fan Z; Yu H; Cui N; Kong X; Liu X; Chang Y; Wu Y; Sun L; Wang G
Exp Cell Res; 2015 Jul; 335(1):68-81. PubMed ID: 25936772
[TBL] [Abstract][Full Text] [Related]
15. Sulforaphane-cysteine induces apoptosis by sustained activation of ERK1/2 and caspase 3 in human glioblastoma U373MG and U87MG cells.
Wu S; Zhou Y; Yang G; Tian H; Geng Y; Hu Y; Lin K; Wu W
Oncol Rep; 2017 May; 37(5):2829-2838. PubMed ID: 28393231
[TBL] [Abstract][Full Text] [Related]
16. Crucifera sulforaphane (SFN) inhibits the growth of nasopharyngeal carcinoma through DNA methyltransferase 1 (DNMT1)/Wnt inhibitory factor 1 (WIF1) axis.
Chen L; Chan LS; Lung HL; Yip TTC; Ngan RKC; Wong JWC; Lo KW; Ng WT; Lee AWM; Tsao GSW; Lung ML; Mak NK
Phytomedicine; 2019 Oct; 63():153058. PubMed ID: 31394414
[TBL] [Abstract][Full Text] [Related]
17. Modulation of cisplatin sensitivity in human ovarian carcinoma A2780 and SKOV3 cell lines by sulforaphane.
Hunakova L; Gronesova P; Horvathova E; Chalupa I; Cholujova D; Duraj J; Sedlak J
Toxicol Lett; 2014 Nov; 230(3):479-86. PubMed ID: 25159039
[TBL] [Abstract][Full Text] [Related]
18. Autophagy inhibition enhances sulforaphane-induced apoptosis in human breast cancer cells.
Kanematsu S; Uehara N; Miki H; Yoshizawa K; Kawanaka A; Yuri T; Tsubura A
Anticancer Res; 2010 Sep; 30(9):3381-90. PubMed ID: 20944112
[TBL] [Abstract][Full Text] [Related]
19. Sulforaphane-induced apoptosis in human leukemia HL-60 cells through extrinsic and intrinsic signal pathways and altering associated genes expression assayed by cDNA microarray.
Shang HS; Shih YL; Lee CH; Hsueh SC; Liu JY; Liao NC; Chen YL; Huang YP; Lu HF; Chung JG
Environ Toxicol; 2017 Jan; 32(1):311-328. PubMed ID: 26833863
[TBL] [Abstract][Full Text] [Related]
20. Sulforaphane Causes Cell Cycle Arrest and Apoptosis in Human Glioblastoma U87MG and U373MG Cell Lines under Hypoxic Conditions.
Sita G; Graziosi A; Hrelia P; Morroni F
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]